NICK BOUKNIGHT

Issues related to appropriate payment legislation for diagnostic radiopharmaceuticals. H.R.1199 - Facilitating Innovative Nuclear Diagnostics Act of 2023.

To gain support for adequate Medicare reimbursement for diagnostic radiopharmaceuticals; H.R.1199 - Facilitating Innovative Nuclear Diagnostics Act of 2023.

To gain support for adequate Medicare reimbursement for diagnostic radiopharmaceuticals; H.R.1199 - Facilitating Innovative Nuclear Diagnostics Act of 2023.

Issues related to appropriate payment legislation for diagnostic radiopharmaceuticals. H.R.1199 - Facilitating Innovative Nuclear Diagnostics Act of 2023.

Issues related to appropriate payment legislation for diagnostic radiopharmaceuticals. H.R.1199 - Facilitating Innovative Nuclear Diagnostics Act of 2023.

Issues related to appropriate payment legislation for diagnostic radiopharmaceuticals. H.R.1199 - Facilitating Innovative Nuclear Diagnostics Act of 2023.

To gain support for adequate Medicare reimbursement for diagnostic radiopharmaceuticals; H.R.1199 - Facilitating Innovative Nuclear Diagnostics Act of 2023.

To gain support for adequate Medicare reimbursement for diagnostic radiopharmaceuticals; H.R.1199 - Facilitating Innovative Nuclear Diagnostics Act of 2023.

To gain support for adequate Medicare reimbursement for diagnostic radiopharmaceuticals; H.R.1199 - Facilitating Innovative Nuclear Diagnostics Act of 2023.

S.4753 - Energy Permitting Reform Act of 2024; S. 2651, the SITE Act; S. 1456, the SPUR Act; S. 1399, the Building American Energy Security Act; S. 1521, Community and Hydropower Improvement Act; S.914, Energy Threat Analysis Center Establishment Act; H.R. 4505, the Hydropower Clean Energy Future Act; H.R. 6747, the Clean Electricity and Transmission Acceleration Act; H.R. 6185, the GRID Act; PEER Act discussion draft; H.R. 6747, Clean Electricity and Transmission Acceleration Act; S. 2827, BIG WIRES; S. 4027, the SPEED and Reliability Act; H.R.1389, GRID Act; S. 4719/H.R. 1389- Guaranteeing Resilient Installations for Defense (GRID) Act of 2024; H.R. 5075, Ethics in Energy Act; H.R. 7624/S. 3918, the Advancing GETs Act; H.R.7171/S. 3627, Distribution Transformer Efficiency and Supply Chain Reliability Act of 2024 H.R. 2864, Countering CCP Drones Act H.R. 8416 - Drones for First Responders Act; H.R. 9083- SECURE Grid Act; American Privacy Rights Act; S. 4664- Department of Energy AI Act; Energy storage generally; Minimum transfer capability; Federal Power Act; Artificial intelligence issues generally; Load growth, reliability, and resource adequacy generally; Data center issues generally; National Interest Electric Transmission Corridors; Nuclear issues generally; Draft legislation related to electric sector emissions reductions; Draft legislation related to offshore wind; Draft legislation related to public safety power shutoffs; Hydrogen policy generally; Electricity transmission and distribution infrastructure generally; Electric transmission policy; Clean energy issues generally; Clean energy technologies generally; Energy storage issues generally; Energy efficiency issues generally; FERC Orders 1920, 2022, 2023; 1977; FERC nominees; FERC issues generally; Offshore wind issues generally; Issues related to energy grid supply chain; Hydropower licensing and re-licensing; Hydrogen policy generally; Draft legislation related to cybersecurity; Draft legislation related to security and data; Distribution transformers.

S. 2651, the SITE Act; S. 1456, the SPUR Act; S. 1399, the Building American Energy Security Act; S. 1521, Community and Hydropower Improvement Act; S.914, Energy Threat Analysis Center Establishment Act; H.R. 4505, the Hydropower Clean Energy Future Act; H.R. 6747, the Clean Electricity and Transmission Acceleration Act; H.R. 4505, the Hydropower Clean Energy Future Act; H.R. 6185, the GRID Act PEER Act discussion draft; H.R. 6747, Clean Electricity and Transmission Acceleration Act; S. 2827, BIG WIRES; S. 4027, the SPEED and Reliability Act; H.R.1389, GRID Act H.R. 5075, Ethics in Energy Act; H.R. 7624/S. 3918, the Advancing GETs Act; H.R.7171/S. 3627, Distribution Transformer Efficiency and Supply Chain Reliability Act of 2024 H.R. 2864, Countering CCP Drones Act Minimum transfer capability; Federal Power Act; Artificial intelligence issues generally; Data center issues generally; Draft legislation related to transmission; Draft legislation related to electric vehicle charging infrastructure Draft legislation related to offshore wind; Draft legislation related to public safety power shutoffs; Hydrogen policy generally; Electricity transmission and distribution infrastructure generally; Electric transmission policy; Clean energy issues generally; Clean energy technologies generally; Energy storage issues generally; Energy efficiency issues generally; FERC issues generally; Offshore wind issues generally; Issues related to energy grid supply chain; Issues related to reliability and resource adequacy generally; Hydropower licensing and re-licensing; Hydrogen policy generally; Draft legislation related to cybersecurity; Draft legislation related to security and data; Distribution transformers.

S.4753 - Energy Permitting Reform Act of 2024; S. 2651, the SITE Act; S. 1456, the SPUR Act; S. 1399, the Building American Energy Security Act; S. 1521, Community and Hydropower Improvement Act; S.914, Energy Threat Analysis Center Establishment Act; H.R. 4505, the Hydropower Clean Energy Future Act; H.R. 6747, the Clean Electricity and Transmission Acceleration Act; H.R. 6185, the GRID Act; PEER Act discussion draft; H.R. 6747, Clean Electricity and Transmission Acceleration Act; S. 2827, BIG WIRES; S. 4027, the SPEED and Reliability Act; H.R.1389, GRID Act; S. 4719- Guaranteeing Resilient Installations for Defense (GRID) Act of 2024; H.R. 5075, Ethics in Energy Act; H.R. 7624/S. 3918, the Advancing GETs Act; H.R.7171/S. 3627, Distribution Transformer Efficiency and Supply Chain Reliability Act of 2024; H.R. 2864, Countering CCP Drones Act; H.R. 8416 - Drones for First Responders Act; H.R. 9083- SECURE Grid Act; American Privacy Rights Act; Energy storage generally; Minimum transfer capability; Federal Power Act; Artificial intelligence issues generally; Load growth, reliability, and resource adequacy generally; Data center issues generally; National Interest Electric Transmission Corridors; Nuclear issues generally; Draft legislation related to electric sector emissions reductions; Draft legislation related to offshore wind; Draft legislation related to public safety power shutoffs; Hydrogen policy generally; Electricity transmission and distribution infrastructure generally; Electric transmission policy; Clean energy issues generally; Clean energy technologies generally; Energy storage issues generally; Energy efficiency issues generally; FERC Orders 1920, 2022, 2023; 1977; FERC nominees; FERC issues generally; Offshore wind issues generally; Issues related to energy grid supply chain; Hydropower licensing and re-licensing; Hydrogen policy generally; Draft legislation related to cybersecurity; Draft legislation related to security and data; Distribution transformers.

S. 2651, the SITE Act; S. 1456, the SPUR Act; S. 1399, the Building American Energy Security Act; S. 1521, Community and Hydropower Improvement Act; S.914, Energy Threat Analysis Center Establishment Act; H.R. 4505, the Hydropower Clean Energy Future Act; H.R. 6747, the Clean Electricity and Transmission Acceleration Act; H.R. 6185, the GRID Act; PEER Act discussion draft; H.R. 6747, Clean Electricity and Transmission Acceleration Act; S. 2827, BIG WIRES; S. 4027, the SPEED and Reliability Act; H.R.1389, GRID Act H.R. 5075, Ethics in Energy Act; H.R. 7624/S. 3918, the Advancing GETs Act; H.R.7171/S. 3627, Distribution Transformer Efficiency and Supply Chain Reliability Act of 2024 H.R. 2864, Countering CCP Drones Act H.R. 8416 - Drones for First Responders Act; American Privacy Rights Act; Energy storage generally; Minimum transfer capability; Federal Power Act; Artificial intelligence issues generally; Load growth and resource adequacy generally; Data center issues generally; National Interest Electric Transmission Corridors; Nuclear issues generally; Draft legislation related to electric sector emissions reductions; Draft legislation related to offshore wind; Draft legislation related to public safety power shutoffs; Hydrogen policy generally; Electricity transmission and distribution infrastructure generally; Electric transmission policy; Clean energy issues generally; Clean energy technologies generally; Energy storage issues generally; Energy efficiency issues generally; FERC Orders 1920, 2022, 2023; 1977 FERC nominees; FERC issues generally; Offshore wind issues generally; Issues related to energy grid supply chain; Issues related to reliability and resource adequacy generally; Hydropower licensing and re-licensing; Hydrogen policy generally; Draft legislation related to cybersecurity; Draft legislation related to security and data; Distribution transformers.

Package Inserts/E-Labeling Issues (H.R. 1503 Prescription Information Modernization Act of 2023). Issues related to the Vaccine Injury Compensation Program.

Package Inserts/E-Labeling Issues (H.R. 1503 Prescription Information Modernization Act of 2023). Issues related to the Vaccine Injury Compensation Program.

Adequacy of Medicare physician payments for physicians and implementation of the Medicare Access and CHIP Reauthorization Act, including related provisions in: (1) S. 4935 Physician Fee Stabilization Act and H.R. 6545, the Physician Fee Schedule Update and Improvements Act, including provisions to increase the work geographic index, increase the Medicare physician fee schedule conversion factor and extend and modify incentive payments for participation in eligible alternative payment models; (2) H.R. 6683, the Preserving Seniors Access to Physicians Act; and (3) H.R. 2474, the Strengthening Medicare for Patients and Providers Act. Issues related to adequate network coverage for ophthalmology care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, including related provisions in: H.R. 4822, the Health Care Price Transparency Act; H.R. 5378, the Lower Costs, More Transparency Act; and S. 4518/S. 4532/H.R. 8702, to establish requirements with respect to the use of prior authorization under Medicare Advantage plans. Medicare reimbursement for telemedicine, including related provisions in S. 3430, the Better Mental Health Care, Lower Costs Drugs, and Extenders Act, including Sec. 105 regarding Medicare payment for mental health services furnished through telehealth, and Sec. 107 regarding communications regarding telehealth and interstate licensure requirements; H.R. 7623, The Telehealth Modernization Act of 2024; SEC. 101. Extension of Certain Telehealth Flexibilities; H.R. 8261, the Preserving Telehealth, Hospital, and Ambulance Access Act; Section 2, extending Medicare Telehealth Flexibilities. Use of step therapy in Medicare and health insurance coverage, including related provisions in H.R. 2630/S. 652, the Safe Step Act. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including monitor CMMI Medicare Part B drug-related demonstrations.

Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act (MACRA), including regulatory relief for physicians in the MACRA Quality Payment Program, evaluation and management (E/M) codes and related legislative issues related to payment for E/M codes, and qualified clinical data registries, including related provisions in H.R. 6545, the Physician Fee Schedule Update and Improvements Act; H.R. 2474, the Strengthening Medicare for Patients and Providers Act; and H.R. 6683, the Preserving Seniors' Access to Physicians Act of 2023. Issues related to adequate network coverage for dermatologic care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, including related provisions in S. 4518/S. 4532/H.R. 8702, to establish requirements with respect to the use of prior authorization under Medicare Advantage plans.

Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act (MACRA), including regulatory relief for physicians in the MACRA Quality Payment Program, evaluation and management (E/M) codes and related legislative issues related to payment for E/M codes, and qualified clinical data registries, including related provisions in S. 4935 Physician Fee Stabilization Act, H.R. 6545, the Physician Fee Schedule Update and Improvements Act; H.R. 2474, the Strengthening Medicare for Patients and Providers Act; and H.R. 6683, the Preserving Seniors' Access to Physicians Act of 2023. Issues related to adequate network coverage for dermatologic care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, including related provisions in S. 4518/S. 4532/H.R. 8702, to establish requirements with respect to the use of prior authorization under Medicare Advantage plans.

Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act (MACRA), including regulatory relief for physicians in the MACRA Quality Payment Program, evaluation and management (E/M) codes and related legislative issues related to payment for E/M codes, and qualified clinical data registries, including related provisions in S. 4935 Physician Fee Stabilization Act, H.R. 6545, the Physician Fee Schedule Update and Improvements Act; H.R. 2474, the Strengthening Medicare for Patients and Providers Act; and H.R. 6683, the Preserving Seniors' Access to Physicians Act of 2023. Issues related to adequate network coverage for dermatologic care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, including related provisions in S. 4518/S. 4532/H.R. 8702, to establish requirements with respect to the use of prior authorization under Medicare Advantage plans.

Adequacy of Medicare physician payments for physicians and implementation of the Medicare Access and CHIP Reauthorization Act, including related provisions in: (1) S. 4935 Physician Fee Stabilization Act and H.R. 6545, the Physician Fee Schedule Update and Improvements Act, including provisions to increase the work geographic index, increase the Medicare physician fee schedule conversion factor and extend and modify incentive payments for participation in eligible alternative payment models; (2) H.R. 6683, the Preserving Seniors Access to Physicians Act; (3) H.R. 2474, the Strengthening Medicare for Patients and Providers Act; and (4) HR ____ Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025-related to physician payment adjustment of 2.5%. Issues related to adequate network coverage for ophthalmology care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, including related provisions in: H.R. 4822, the Health Care Price Transparency Act; H.R. 5378, the Lower Costs, More Transparency Act; and S. 4518/S. 4532/H.R. 8702, to establish requirements with respect to the use of prior authorization under Medicare Advantage plans. Medicare reimbursement for telemedicine, including related provisions in S. 3430, the Better Mental Health Care, Lower Costs Drugs, and Extenders Act, including Sec. 105 regarding Medicare payment for mental health services furnished through telehealth, and Sec. 107 regarding communications regarding telehealth and interstate licensure requirements; H.R. 7623, The Telehealth Modernization Act of 2024; SEC. 101. Extension of Certain Telehealth Flexibilities; H.R. 8261, the Preserving Telehealth, Hospital, and Ambulance Access Act; Section 2, extending Medicare Telehealth Flexibilities. Use of step therapy in Medicare and health insurance coverage, including related provisions in H.R. 2630/S. 652, the Safe Step Act. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including monitor CMMI Medicare Part B drug-related demonstrations.

Legislative and regulatory issues related to physical therapy. Workforce issues, including S.2459 - Enabling More of the Physical and Occupational Workforce to Engage in Rehabilitation Act. Pelvic Health, including H.R.2480 - Optimizing Postpartum Outcomes Act of 2023 and issues related to PT in the military. Remove Duplicative Unnecessary Clerical Exchanges Act or REDUCE Act (H.R. 7279).

Legislative and regulatory issues related to physical therapy. Workforce issues, including S.2459 - Enabling More of the Physical and Occupational Workforce to Engage in Rehabilitation Act. Pelvic Health, including H.R.2480 - Optimizing Postpartum Outcomes Act of 2023 and issues related to PT in the military.

Legislative and regulatory issues related to physical therapy. Workforce issues, including S.2459 - Enabling More of the Physical and Occupational Workforce to Engage in Rehabilitation Act. Pelvic Health, including H.R.2480 - Optimizing Postpartum Outcomes Act of 2023 and issues related to PT in the military. Remove Duplicative Unnecessary Clerical Exchanges Act or REDUCE Act (H.R. 7279).

Legislative and regulatory issues related to physical therapy. Workforce issues, including S.2459 - Enabling More of the Physical and Occupational Workforce to Engage in Rehabilitation Act. Pelvic Health, including H.R.2480 - Optimizing Postpartum Outcomes Act of 2023 and issues related to PT in the military. Remove Duplicative Unnecessary Clerical Exchanges Act or REDUCE Act (H.R. 7279).

Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP ReauthorizationAct (MACRA), including regulatory relief for physicians in the MACRA Quality Payment Program, evaluation and management (E/M) codes andrelated legislative issues related to payment for E/M codes, and qualified clinical data registries, including Medicare physician payment provisions in:(1) S. 3430, the Better Mental Health Care, Lower-Cost Drugs, and Extenders Act, Sec. 403 to extend work geographic index floor under Medicare; Sec. 404 to extend incentive payments for participation in eligible alternative payment models; and Sec. 407 to increase support for physicians and other professionals in adjusting to Medicare payment changes; (2) H.R. 6545, the Physician Fee Schedule Update and Improvements Act, including provisions to increase the work geographic index, increase the Medicare physician fee schedule conversion factor and extend and modify incentive payments for participation in eligible alternative payment models; and (3) H.R. 4366, the Consolidated Appropriations Act, 2024, P.L. 118-42: Sec.304, Extending Incentive Payments for Participation in Eligible Alternative Payment Models; and Sec. 305, Temporary Payment Increase under the Medicare Physician Fee Schedule to Account for Exceptional Circumstances and Atypical Timing of Enactment. Maintain patient access to In-Office Ancillary Services. Issues related to adequate network coverage for ophthalmology care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, including related provisions in: H.R. 4822, the Health Care Price Transparency Act; H.R. 5378, the Lower Costs, More Transparency Act; and S. 4518/S. 4532/H.R. 8702, to establish requirements with respect to the use of prior authorization under Medicare Advantage plans. MA plan provider directory accuracy issues, including related provisions in S. 3430, the Better Mental Health Care, Lower Cost Drugs, and Extenders Act of 2023, in Sec. 109, to require MA plans to maintain accurate provider directories on a public website. Legislative issues regarding implementation of Meaningful Use of Electronic Health Records. Medicare reimbursement for telemedicine, including related provisions in S. 3430, the Better Mental Health Care, Lower Costs Drugs, and Extenders Act, including Sec. 105 regarding Medicare payment for mental health services furnished through telehealth, and Sec. 107 regarding communications regarding telehealth and interstate licensure requirements; H.R. 7623, The Telehealth Modernization Act of 2024; SEC. 101. Extension of Certain Telehealth Flexibilities; H.R. 8261, the Preserving Telehealth, Hospital, and Ambulance Access Act; Section 2, extending Medicare Telehealth Flexibilities. Medicare RAC reform and use of step therapy in Medicare and health insurance coverage including related provisions in H.R. 2630/S. 652, the SafeStep Act. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including monitor CMMI Medicare Part B drug-related demonstrations.

340B Program issues and patient access to pharmaceuticals, including related provisions in H.R. 3290, to amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program." Legislative issues associated with patient access to treatment, including: the CMMI Most Favored Nation and related demonstration initiatives; and step therapy, including related provisions in H.R. 2630/S. 652, the Safe Step Act. Medical Supply Chain, including issues related to a new rating system; targeted action to support the diversification of certain supplies; additional funding to the Strategic National Stockpile (SNS) and more diverse stockpile; increasing flexibility for supply chains. Enhanced FDA reporting and risk mitigation plans for certain medicines. Incentives for antimicrobial and antiviral research and novel product development.

340B Program issues and patient access to pharmaceuticals, including related provisions in H.R. 3290, to amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program." Legislative issues associated with patient access to treatment, including: the CMMI Most Favored Nation and related demonstration initiatives; and step therapy, including related provisions in H.R. 2630/S. 652, the Safe Step Act. Medical Supply Chain, including issues related to a new rating system; targeted action to support the diversification of certain supplies; additional funding to the Strategic National Stockpile (SNS) and more diverse stockpile; increasing flexibility for supply chains. Enhanced FDA reporting and risk mitigation plans for certain medicines. Incentives for antimicrobial and antiviral research, medical countermeasures, and novel product development.

Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act (MACRA), including regulatory relief for physicians in the MACRA Quality Payment Program, evaluation and management (E/M) codes and related legislative issues related to payment for E/M codes, and qualified clinical data registries, including Medicare physician payment provisions in: (1) S. 3430, the Better Mental Health Care, Lower-Cost Drugs, and Extenders Act, Sec. 403 to extend work geographic index floor under Medicare; Sec. 404 to extend incentive payments for participation in eligible alternative payment models; and Sec. 407 to increase support for physicians and other professionals in adjusting to Medicare payment changes; (2) H.R. 6545, the Physician Fee Schedule Update and Improvements Act, including provisions to increase the work geographic index, increase the Medicare physician fee schedule conversion factor and extend and modify incentive payments for participation in eligible alternative payment models; and (3) H.R. 4366, the Consolidated Appropriations Act, 2024, P.L. 118-42: Sec. 304, Extending Incentive Payments for Participation in Eligible Alternative Payment Models; and Sec. 305, Temporary Payment Increase under the Medicare Physician Fee Schedule to Account for Exceptional Circumstances and Atypical Timing of Enactment. Maintain patient access to In-Office Ancillary Services. Issues related to adequate network coverage for ophthalmology care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, including related provisions in: (1) H.R. 4822, the Health Care Price Transparency Act, to require Medicare Advantage plans to institute electronic prior authorization and establish requirements related to real time decisions; and (2) prior authorization transparency requirements included in H.R. 5378, the Lower Costs, More Transparency Act, and H.R. 4822, the Health Care Price Transparency Act; and MA plan provider directory accuracy issues, including provisions in S. 3430, the Better Mental Health Care, Lower Cost Drugs, and Extenders Act of 2023, in Sec. 109, to require MA plans to maintain accurate provider directories on a public website. Legislative issues regarding implementation of Meaningful Use of Electronic Health Records. Medicare reimbursement for telemedicine, including related provisions in S. 3430, the Better Mental Health Care, Lower Costs Drugs, and Extenders Act, including Sec. 105 regarding Medicare payment for mental health services furnished through telehealth, and Sec. 107 regarding communications regarding telehealth and interstate licensure requirements. Medicare RAC reform and use of step therapy in Medicare and health insurance coverage including related provisions in H.R. 2630/S. 652, the Safe Step Act. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including monitor CMMI Medicare Part B drug-related demonstrations.

Adequacy of Medicare physician payments for physicians and implementation of the Medicare Access and CHIP Reauthorization Act, including related provisions in: (1) S. 4935 Physician Fee Stabilization Act and H.R. 6545, the Physician Fee Schedule Update and Improvements Act, including provisions to increase the work geographic index, increase the Medicare physician fee schedule conversion factor and extend and modify incentive payments for participation in eligible alternative payment models; (2) H.R. 6683, the Preserving Seniors Access to Physicians Act; (3) H.R. 2474, the Strengthening Medicare for Patients and Providers Act; and (4) HR ____ Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025-related to physician payment adjustment of 2.5%. Issues related to adequate network coverage for ophthalmology care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, including related provisions in: H.R. 4822, the Health Care Price Transparency Act; H.R. 5378, the Lower Costs, More Transparency Act; and S. 4518/S. 4532/H.R. 8702, to establish requirements with respect to the use of prior authorization under Medicare Advantage plans. Medicare reimbursement for telemedicine, including related provisions in S. 3430, the Better Mental Health Care, Lower Costs Drugs, and Extenders Act, including Sec. 105 regarding Medicare payment for mental health services furnished through telehealth, and Sec. 107 regarding communications regarding telehealth and interstate licensure requirements; H.R. 7623, The Telehealth Modernization Act of 2024; SEC. 101. Extension of Certain Telehealth Flexibilities; H.R. 8261, the Preserving Telehealth, Hospital, and Ambulance Access Act; Section 2, extending Medicare Telehealth Flexibilities. Use of step therapy in Medicare and health insurance coverage, including related provisions in H.R. 2630/S. 652, the Safe Step Act. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including monitor CMMI Medicare Part B drug-related demonstrations.

Adequacy of Medicare physician payments for physicians and implementation of the Medicare Access and CHIP Reauthorization Act, including related provisions in: (1) S. 4935 Physician Fee Stabilization Act and H.R. 6545, the Physician Fee Schedule Update and Improvements Act, including provisions to increase the work geographic index, increase the Medicare physician fee schedule conversion factor and extend and modify incentive payments for participation in eligible alternative payment models; (2) H.R. 6683, the Preserving Seniors Access to Physicians Act; and (3) H.R. 2474, the Strengthening Medicare for Patients and Providers Act. Issues related to adequate network coverage for ophthalmology care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, including related provisions in: H.R. 4822, the Health Care Price Transparency Act; H.R. 5378, the Lower Costs, More Transparency Act; and S. 4518/S. 4532/H.R. 8702, to establish requirements with respect to the use of prior authorization under Medicare Advantage plans. Medicare reimbursement for telemedicine, including related provisions in S. 3430, the Better Mental Health Care, Lower Costs Drugs, and Extenders Act, including Sec. 105 regarding Medicare payment for mental health services furnished through telehealth, and Sec. 107 regarding communications regarding telehealth and interstate licensure requirements; H.R. 7623, The Telehealth Modernization Act of 2024; SEC. 101. Extension of Certain Telehealth Flexibilities; H.R. 8261, the Preserving Telehealth, Hospital, and Ambulance Access Act; Section 2, extending Medicare Telehealth Flexibilities. Use of step therapy in Medicare and health insurance coverage, including related provisions in H.R. 2630/S. 652, the Safe Step Act. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including monitor CMMI Medicare Part B drug-related demonstrations.

Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act (MACRA), including regulatory relief for physicians in the MACRA Quality Payment Program, evaluation and management (E/M) codes and related legislative issues related to payment for E/M codes, and qualified clinical data registries. Maintain patient access to In-Office Ancillary Services. Issues related to adequate network coverage for dermatologic care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans. Legislative issues regarding implementation of Meaningful Use of Electronic Health Records. Medicare reimbursement for telemedicine. Medicare RAC reform and use of step therapy in Medicare and health insurance coverage including related provisions in H.R. 2630/S. 652, the Safe Step Act. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including monitor CMMI Medicare Part B drug-related demonstrations.

340B Program issues and patient access to pharmaceuticals, including related provisions in H.R. 3290, to amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program." Legislative issues associated with patient access to treatment, including: the CMMI Most Favored Nation and related demonstration initiatives; and step therapy, including related provisions in H.R. 2630/S. 652, the Safe Step Act. Medical Supply Chain, including issues related to a new rating system; targeted action to support the diversification of certain supplies; additional funding to the Strategic National Stockpile (SNS) and more diverse stockpile; increasing flexibility for supply chains. Enhanced FDA reporting and risk mitigation plans for certain medicines. Incentives for antimicrobial and antiviral research and novel product development.

340B Program issues and patient access to pharmaceuticals, including related provisions in H.R. 3290, to amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program." Legislative issues associated with patient access to treatment, including: the CMMI Most Favored Nation and related demonstration initiatives; and step therapy, including related provisions in H.R. 2630/S. 652, the Safe Step Act. Medical Supply Chain, including issues related to a new rating system; targeted action to support the diversification of certain supplies; additional funding to the Strategic National Stockpile (SNS) and more diverse stockpile; increasing flexibility for supply chains. Enhanced FDA reporting and risk mitigation plans for certain medicines. Incentives for antimicrobial and antiviral research, medical countermeasures, and novel product development.

S.4753 - Energy Permitting Reform Act of 2024; S. 2651, the SITE Act; S. 1456, the SPUR Act; S. 1399, the Building American Energy Security Act; S. 1521, Community and Hydropower Improvement Act; S.914, Energy Threat Analysis Center Establishment Act; H.R. 4505, the Hydropower Clean Energy Future Act; H.R. 6747, the Clean Electricity and Transmission Acceleration Act; H.R. 6185, the GRID Act; PEER Act discussion draft; H.R. 6747, Clean Electricity and Transmission Acceleration Act; S. 2827, BIG WIRES; S. 4027, the SPEED and Reliability Act; H.R.1389, GRID Act; S. 4719/H.R. 1389- Guaranteeing Resilient Installations for Defense (GRID) Act of 2024; H.R. 5075, Ethics in Energy Act; H.R. 7624/S. 3918, the Advancing GETs Act; H.R.7171/S. 3627, Distribution Transformer Efficiency and Supply Chain Reliability Act of 2024 H.R. 2864, Countering CCP Drones Act H.R. 8416 - Drones for First Responders Act; H.R. 9083- SECURE Grid Act; American Privacy Rights Act; S. 4664- Department of Energy AI Act; Energy storage generally; Minimum transfer capability; Federal Power Act; Artificial intelligence issues generally; Load growth, reliability, and resource adequacy generally; Data center issues generally; National Interest Electric Transmission Corridors; Nuclear issues generally; Draft legislation related to electric sector emissions reductions; Draft legislation related to offshore wind; Draft legislation related to public safety power shutoffs; Hydrogen policy generally; Electricity transmission and distribution infrastructure generally; Electric transmission policy; Clean energy issues generally; Clean energy technologies generally; Energy storage issues generally; Energy efficiency issues generally; FERC Orders 1920, 2022, 2023; 1977; FERC nominees; FERC issues generally; Offshore wind issues generally; Issues related to energy grid supply chain; Hydropower licensing and re-licensing; Hydrogen policy generally; Draft legislation related to cybersecurity; Draft legislation related to security and data; Distribution transformers.

S. 2651, the SITE Act; S. 1456, the SPUR Act; S. 1399, the Building American Energy Security Act; S. 1521, Community and Hydropower Improvement Act; S.914, Energy Threat Analysis Center Establishment Act; H.R. 4505, the Hydropower Clean Energy Future Act; H.R. 6747, the Clean Electricity and Transmission Acceleration Act; H.R. 6185, the GRID Act; PEER Act discussion draft; H.R. 6747, Clean Electricity and Transmission Acceleration Act; S. 2827, BIG WIRES; S. 4027, the SPEED and Reliability Act; H.R.1389, GRID Act H.R. 5075, Ethics in Energy Act; H.R. 7624/S. 3918, the Advancing GETs Act; H.R.7171/S. 3627, Distribution Transformer Efficiency and Supply Chain Reliability Act of 2024 H.R. 2864, Countering CCP Drones Act H.R. 8416 - Drones for First Responders Act; American Privacy Rights Act; Energy storage generally; Minimum transfer capability; Federal Power Act; Artificial intelligence issues generally; Load growth and resource adequacy generally; Data center issues generally; National Interest Electric Transmission Corridors; Nuclear issues generally; Draft legislation related to electric sector emissions reductions; Draft legislation related to offshore wind; Draft legislation related to public safety power shutoffs; Hydrogen policy generally; Electricity transmission and distribution infrastructure generally; Electric transmission policy; Clean energy issues generally; Clean energy technologies generally; Energy storage issues generally; Energy efficiency issues generally; FERC Orders 1920, 2022, 2023; 1977 FERC nominees; FERC issues generally; Offshore wind issues generally; Issues related to energy grid supply chain; Issues related to reliability and resource adequacy generally; Hydropower licensing and re-licensing; Hydrogen policy generally; Draft legislation related to cybersecurity; Draft legislation related to security and data; Distribution transformers.

S. 2651, the SITE Act; S. 1456, the SPUR Act; S. 1399, the Building American Energy Security Act; S. 1521, Community and Hydropower Improvement Act; S.914, Energy Threat Analysis Center Establishment Act; H.R. 4505, the Hydropower Clean Energy Future Act; H.R. 6747, the Clean Electricity and Transmission Acceleration Act; H.R. 4505, the Hydropower Clean Energy Future Act; H.R. 6185, the GRID Act PEER Act discussion draft; H.R. 6747, Clean Electricity and Transmission Acceleration Act; S. 2827, BIG WIRES; S. 4027, the SPEED and Reliability Act; H.R.1389, GRID Act H.R. 5075, Ethics in Energy Act; H.R. 7624/S. 3918, the Advancing GETs Act; H.R.7171/S. 3627, Distribution Transformer Efficiency and Supply Chain Reliability Act of 2024 H.R. 2864, Countering CCP Drones Act Minimum transfer capability; Federal Power Act; Artificial intelligence issues generally; Data center issues generally; Draft legislation related to transmission; Draft legislation related to electric vehicle charging infrastructure Draft legislation related to offshore wind; Draft legislation related to public safety power shutoffs; Hydrogen policy generally; Electricity transmission and distribution infrastructure generally; Electric transmission policy; Clean energy issues generally; Clean energy technologies generally; Energy storage issues generally; Energy efficiency issues generally; FERC issues generally; Offshore wind issues generally; Issues related to energy grid supply chain; Issues related to reliability and resource adequacy generally; Hydropower licensing and re-licensing; Hydrogen policy generally; Draft legislation related to cybersecurity; Draft legislation related to security and data; Distribution transformers.

S.4753 - Energy Permitting Reform Act of 2024; S. 2651, the SITE Act; S. 1456, the SPUR Act; S. 1399, the Building American Energy Security Act; S. 1521, Community and Hydropower Improvement Act; S.914, Energy Threat Analysis Center Establishment Act; H.R. 4505, the Hydropower Clean Energy Future Act; H.R. 6747, the Clean Electricity and Transmission Acceleration Act; H.R. 6185, the GRID Act; PEER Act discussion draft; H.R. 6747, Clean Electricity and Transmission Acceleration Act; S. 2827, BIG WIRES; S. 4027, the SPEED and Reliability Act; H.R.1389, GRID Act; S. 4719- Guaranteeing Resilient Installations for Defense (GRID) Act of 2024; H.R. 5075, Ethics in Energy Act; H.R. 7624/S. 3918, the Advancing GETs Act; H.R.7171/S. 3627, Distribution Transformer Efficiency and Supply Chain Reliability Act of 2024; H.R. 2864, Countering CCP Drones Act; H.R. 8416 - Drones for First Responders Act; H.R. 9083- SECURE Grid Act; American Privacy Rights Act; Energy storage generally; Minimum transfer capability; Federal Power Act; Artificial intelligence issues generally; Load growth, reliability, and resource adequacy generally; Data center issues generally; National Interest Electric Transmission Corridors; Nuclear issues generally; Draft legislation related to electric sector emissions reductions; Draft legislation related to offshore wind; Draft legislation related to public safety power shutoffs; Hydrogen policy generally; Electricity transmission and distribution infrastructure generally; Electric transmission policy; Clean energy issues generally; Clean energy technologies generally; Energy storage issues generally; Energy efficiency issues generally; FERC Orders 1920, 2022, 2023; 1977; FERC nominees; FERC issues generally; Offshore wind issues generally; Issues related to energy grid supply chain; Hydropower licensing and re-licensing; Hydrogen policy generally; Draft legislation related to cybersecurity; Draft legislation related to security and data; Distribution transformers.

Issues related to Medicare Part D and prescription drug pricing and patient access, including monitor implementation of related provisions in H.R. 5376, the Inflation Reduction Act of 2022 (P.L. 117-169), including provisions in Title 1, Subtitle B - Prescription Drug Pricing Reform: Part 1, Lowering Prices Through Drug Price Negotiation; Part 2, Prescription Drug Inflation Rebates; and Part 3, Part D Improvements and Maximum Out-of-Pocket Cap for Medicare Beneficiaries. Issues related to pharmacy benefit manager transparency, including related provisions in S. 2973, the Modernizing and Ensuring PBM Accountability Act, H.R. 5378, the Lower Costs, More Transparency Act, H.R. 4822, the Health Care Price Transparency Act; H.R. 2880, the Protecting Patients Against PBM Abuses Act, including provisions to establish new requirements for PBMs in Medicare Part D; and H.R. 5385, the Medicare PBM Accountability Act, including provisions to enhance PBM reporting requirements and reporting drug pricing information to HHS.

340B Program issues and patient access to pharmaceuticals, including related provisions in H.R. 3290, to amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program." Legislative issues associated with patient access to treatment, including: the CMMI Most Favored Nation and related demonstration initiatives; and step therapy, including related provisions in H.R. 2630/S. 652, the Safe Step Act. Medical Supply Chain, including issues related to a new rating system; targeted action to support the diversification of certain supplies; additional funding to the Strategic National Stockpile (SNS) and more diverse stockpile; increasing flexibility for supply chains. Enhanced FDA reporting and risk mitigation plans for certain medicines. Incentives for antimicrobial and antiviral research and novel product development.

340B Program issues and patient access to pharmaceuticals, including related provisions in H.R. 3290, to amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program." Legislative issues associated with patient access to treatment, including: the CMMI Most Favored Nation and related demonstration initiatives; and step therapy, including related provisions in H.R. 2630/S. 652, the Safe Step Act. Medical Supply Chain, including issues related to a new rating system; targeted action to support the diversification of certain supplies; additional funding to the Strategic National Stockpile (SNS) and more diverse stockpile; increasing flexibility for supply chains. Enhanced FDA reporting and risk mitigation plans for certain medicines. Incentives for antimicrobial and antiviral research and novel product development.

340B Program issues and patient access to pharmaceuticals, including related provisions in H.R. 3290, to amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program." Legislative issues associated with patient access to treatment, including: the CMMI Most Favored Nation and related demonstration initiatives; and step therapy, including related provisions in H.R. 2630/S. 652, the Safe Step Act. Medical Supply Chain, including issues related to a new rating system; targeted action to support the diversification of certain supplies; additional funding to the Strategic National Stockpile (SNS) and more diverse stockpile; increasing flexibility for supply chains. Enhanced FDA reporting and risk mitigation plans for certain medicines. Incentives for antimicrobial and antiviral research, medical countermeasures, and novel product development.

340B Program issues and patient access to pharmaceuticals, including related provisions in H.R. 3290, to amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program." Legislative issues associated with patient access to treatment, including: the CMMI Most Favored Nation and related demonstration initiatives; and step therapy, including related provisions in H.R. 2630/S. 652, the Safe Step Act. Medical Supply Chain, including issues related to a new rating system; targeted action to support the diversification of certain supplies; additional funding to the Strategic National Stockpile (SNS) and more diverse stockpile; increasing flexibility for supply chains. Enhanced FDA reporting and risk mitigation plans for certain medicines. Incentives for antimicrobial and antiviral research, medical countermeasures, and novel product development.

Issues regarding aerial security in the FAA Reauthorization (H.R.3935 - Securing Growth and Robust Leadership in American Aviation Act) and S.1631/H.R. 4333 - Safeguarding the Homeland from the Threats Posed by Unmanned Aircraft Systems Act of 2023.

Issues regarding aerial security in the FAA Reauthorization (H.R.3935 - Securing Growth and Robust Leadership in American Aviation Act) and S.1631/H.R. 4333 - Safeguarding the Homeland from the Threats Posed by Unmanned Aircraft Systems Act of 2023.

Issues regarding aerial security in the FAA Reauthorization (H.R.3935 - Securing Growth and Robust Leadership in American Aviation Act) and S.1631/H.R. 4333 - Safeguarding the Homeland from the Threats Posed by Unmanned Aircraft Systems Act of 2023.

Issues regarding aerial security in the FAA Reauthorization (H.R.3935 - Securing Growth and Robust Leadership in American Aviation Act) and S.1631/H.R. 4333 - Safeguarding the Homeland from the Threats Posed by Unmanned Aircraft Systems Act of 2023.

Issues regarding aerial security, S.1631/H.R. 4333 - Safeguarding the Homeland from the Threats Posed by Unmanned Aircraft Systems Act of 2023.

Issues regarding aerial security, S.1631/H.R. 4333 - Safeguarding the Homeland from the Threats Posed by Unmanned Aircraft Systems Act of 2023.

Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP ReauthorizationAct (MACRA), including regulatory relief for physicians in the MACRA Quality Payment Program, evaluation and management (E/M) codes andrelated legislative issues related to payment for E/M codes, and qualified clinical data registries, including Medicare physician payment provisions in:(1) S. 3430, the Better Mental Health Care, Lower-Cost Drugs, and Extenders Act, Sec. 403 to extend work geographic index floor under Medicare; Sec. 404 to extend incentive payments for participation in eligible alternative payment models; and Sec. 407 to increase support for physicians and other professionals in adjusting to Medicare payment changes; (2) H.R. 6545, the Physician Fee Schedule Update and Improvements Act, including provisions to increase the work geographic index, increase the Medicare physician fee schedule conversion factor and extend and modify incentive payments for participation in eligible alternative payment models; and (3) H.R. 4366, the Consolidated Appropriations Act, 2024, P.L. 118-42: Sec.304, Extending Incentive Payments for Participation in Eligible Alternative Payment Models; and Sec. 305, Temporary Payment Increase under the Medicare Physician Fee Schedule to Account for Exceptional Circumstances and Atypical Timing of Enactment. Maintain patient access to In-Office Ancillary Services. Issues related to adequate network coverage for ophthalmology care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, including related provisions in: H.R. 4822, the Health Care Price Transparency Act; H.R. 5378, the Lower Costs, More Transparency Act; and S. 4518/S. 4532/H.R. 8702, to establish requirements with respect to the use of prior authorization under Medicare Advantage plans. MA plan provider directory accuracy issues, including related provisions in S. 3430, the Better Mental Health Care, Lower Cost Drugs, and Extenders Act of 2023, in Sec. 109, to require MA plans to maintain accurate provider directories on a public website. Legislative issues regarding implementation of Meaningful Use of Electronic Health Records. Medicare reimbursement for telemedicine, including related provisions in S. 3430, the Better Mental Health Care, Lower Costs Drugs, and Extenders Act, including Sec. 105 regarding Medicare payment for mental health services furnished through telehealth, and Sec. 107 regarding communications regarding telehealth and interstate licensure requirements; H.R. 7623, The Telehealth Modernization Act of 2024; SEC. 101. Extension of Certain Telehealth Flexibilities; H.R. 8261, the Preserving Telehealth, Hospital, and Ambulance Access Act; Section 2, extending Medicare Telehealth Flexibilities. Medicare RAC reform and use of step therapy in Medicare and health insurance coverage including related provisions in H.R. 2630/S. 652, the SafeStep Act. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including monitor CMMI Medicare Part B drug-related demonstrations.

Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act (MACRA), including regulatory relief for physicians in the MACRA Quality Payment Program, evaluation and management (E/M) codes and related legislative issues related to payment for E/M codes, and qualified clinical data registries, including Medicare physician payment provisions in: (1) S. 3430, the Better Mental Health Care, Lower-Cost Drugs, and Extenders Act, Sec. 403 to extend work geographic index floor under Medicare; Sec. 404 to extend incentive payments for participation in eligible alternative payment models; and Sec. 407 to increase support for physicians and other professionals in adjusting to Medicare payment changes; (2) H.R. 6545, the Physician Fee Schedule Update and Improvements Act, including provisions to increase the work geographic index, increase the Medicare physician fee schedule conversion factor and extend and modify incentive payments for participation in eligible alternative payment models; and (3) H.R. 4366, the Consolidated Appropriations Act, 2024, P.L. 118-42: Sec. 304, Extending Incentive Payments for Participation in Eligible Alternative Payment Models; and Sec. 305, Temporary Payment Increase under the Medicare Physician Fee Schedule to Account for Exceptional Circumstances and Atypical Timing of Enactment. Maintain patient access to In-Office Ancillary Services. Issues related to adequate network coverage for ophthalmology care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, including related provisions in: (1) H.R. 4822, the Health Care Price Transparency Act, to require Medicare Advantage plans to institute electronic prior authorization and establish requirements related to real time decisions; and (2) prior authorization transparency requirements included in H.R. 5378, the Lower Costs, More Transparency Act, and H.R. 4822, the Health Care Price Transparency Act; and MA plan provider directory accuracy issues, including provisions in S. 3430, the Better Mental Health Care, Lower Cost Drugs, and Extenders Act of 2023, in Sec. 109, to require MA plans to maintain accurate provider directories on a public website. Legislative issues regarding implementation of Meaningful Use of Electronic Health Records. Medicare reimbursement for telemedicine, including related provisions in S. 3430, the Better Mental Health Care, Lower Costs Drugs, and Extenders Act, including Sec. 105 regarding Medicare payment for mental health services furnished through telehealth, and Sec. 107 regarding communications regarding telehealth and interstate licensure requirements. Medicare RAC reform and use of step therapy in Medicare and health insurance coverage including related provisions in H.R. 2630/S. 652, the Safe Step Act. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including monitor CMMI Medicare Part B drug-related demonstrations.

S. 2651, the SITE Act; S. 1456, the SPUR Act; S. 1399, the Building American Energy Security Act; S. 1521, Community and Hydropower Improvement Act; S.914, Energy Threat Analysis Center Establishment Act; H.R. 4505, the Hydropower Clean Energy Future Act; H.R. 6747, the Clean Electricity and Transmission Acceleration Act; H.R. 6185, the GRID Act; PEER Act discussion draft; H.R. 6747, Clean Electricity and Transmission Acceleration Act; S. 2827, BIG WIRES; S. 4027, the SPEED and Reliability Act; H.R.1389, GRID Act H.R. 5075, Ethics in Energy Act; H.R. 7624/S. 3918, the Advancing GETs Act; H.R.7171/S. 3627, Distribution Transformer Efficiency and Supply Chain Reliability Act of 2024 H.R. 2864, Countering CCP Drones Act H.R. 8416 - Drones for First Responders Act; American Privacy Rights Act; Energy storage generally; Minimum transfer capability; Federal Power Act; Artificial intelligence issues generally; Load growth and resource adequacy generally; Data center issues generally; National Interest Electric Transmission Corridors; Nuclear issues generally; Draft legislation related to electric sector emissions reductions; Draft legislation related to offshore wind; Draft legislation related to public safety power shutoffs; Hydrogen policy generally; Electricity transmission and distribution infrastructure generally; Electric transmission policy; Clean energy issues generally; Clean energy technologies generally; Energy storage issues generally; Energy efficiency issues generally; FERC Orders 1920, 2022, 2023; 1977 FERC nominees; FERC issues generally; Offshore wind issues generally; Issues related to energy grid supply chain; Issues related to reliability and resource adequacy generally; Hydropower licensing and re-licensing; Hydrogen policy generally; Draft legislation related to cybersecurity; Draft legislation related to security and data; Distribution transformers.

S.4753 - Energy Permitting Reform Act of 2024; S. 2651, the SITE Act; S. 1456, the SPUR Act; S. 1399, the Building American Energy Security Act; S. 1521, Community and Hydropower Improvement Act; S.914, Energy Threat Analysis Center Establishment Act; H.R. 4505, the Hydropower Clean Energy Future Act; H.R. 6747, the Clean Electricity and Transmission Acceleration Act; H.R. 6185, the GRID Act; PEER Act discussion draft; H.R. 6747, Clean Electricity and Transmission Acceleration Act; S. 2827, BIG WIRES; S. 4027, the SPEED and Reliability Act; H.R.1389, GRID Act; S. 4719/H.R. 1389- Guaranteeing Resilient Installations for Defense (GRID) Act of 2024; H.R. 5075, Ethics in Energy Act; H.R. 7624/S. 3918, the Advancing GETs Act; H.R.7171/S. 3627, Distribution Transformer Efficiency and Supply Chain Reliability Act of 2024 H.R. 2864, Countering CCP Drones Act H.R. 8416 - Drones for First Responders Act; H.R. 9083- SECURE Grid Act; American Privacy Rights Act; S. 4664- Department of Energy AI Act; Energy storage generally; Minimum transfer capability; Federal Power Act; Artificial intelligence issues generally; Load growth, reliability, and resource adequacy generally; Data center issues generally; National Interest Electric Transmission Corridors; Nuclear issues generally; Draft legislation related to electric sector emissions reductions; Draft legislation related to offshore wind; Draft legislation related to public safety power shutoffs; Hydrogen policy generally; Electricity transmission and distribution infrastructure generally; Electric transmission policy; Clean energy issues generally; Clean energy technologies generally; Energy storage issues generally; Energy efficiency issues generally; FERC Orders 1920, 2022, 2023; 1977; FERC nominees; FERC issues generally; Offshore wind issues generally; Issues related to energy grid supply chain; Hydropower licensing and re-licensing; Hydrogen policy generally; Draft legislation related to cybersecurity; Draft legislation related to security and data; Distribution transformers.

S. 2651, the SITE Act; S. 1456, the SPUR Act; S. 1399, the Building American Energy Security Act; S. 1521, Community and Hydropower Improvement Act; S.914, Energy Threat Analysis Center Establishment Act; H.R. 4505, the Hydropower Clean Energy Future Act; H.R. 6747, the Clean Electricity and Transmission Acceleration Act; H.R. 4505, the Hydropower Clean Energy Future Act; H.R. 6185, the GRID Act PEER Act discussion draft; H.R. 6747, Clean Electricity and Transmission Acceleration Act; S. 2827, BIG WIRES; S. 4027, the SPEED and Reliability Act; H.R.1389, GRID Act H.R. 5075, Ethics in Energy Act; H.R. 7624/S. 3918, the Advancing GETs Act; H.R.7171/S. 3627, Distribution Transformer Efficiency and Supply Chain Reliability Act of 2024 H.R. 2864, Countering CCP Drones Act Minimum transfer capability; Federal Power Act; Artificial intelligence issues generally; Data center issues generally; Draft legislation related to transmission; Draft legislation related to electric vehicle charging infrastructure Draft legislation related to offshore wind; Draft legislation related to public safety power shutoffs; Hydrogen policy generally; Electricity transmission and distribution infrastructure generally; Electric transmission policy; Clean energy issues generally; Clean energy technologies generally; Energy storage issues generally; Energy efficiency issues generally; FERC issues generally; Offshore wind issues generally; Issues related to energy grid supply chain; Issues related to reliability and resource adequacy generally; Hydropower licensing and re-licensing; Hydrogen policy generally; Draft legislation related to cybersecurity; Draft legislation related to security and data; Distribution transformers.

S.4753 - Energy Permitting Reform Act of 2024; S. 2651, the SITE Act; S. 1456, the SPUR Act; S. 1399, the Building American Energy Security Act; S. 1521, Community and Hydropower Improvement Act; S.914, Energy Threat Analysis Center Establishment Act; H.R. 4505, the Hydropower Clean Energy Future Act; H.R. 6747, the Clean Electricity and Transmission Acceleration Act; H.R. 6185, the GRID Act; PEER Act discussion draft; H.R. 6747, Clean Electricity and Transmission Acceleration Act; S. 2827, BIG WIRES; S. 4027, the SPEED and Reliability Act; H.R.1389, GRID Act; S. 4719- Guaranteeing Resilient Installations for Defense (GRID) Act of 2024; H.R. 5075, Ethics in Energy Act; H.R. 7624/S. 3918, the Advancing GETs Act; H.R.7171/S. 3627, Distribution Transformer Efficiency and Supply Chain Reliability Act of 2024; H.R. 2864, Countering CCP Drones Act; H.R. 8416 - Drones for First Responders Act; H.R. 9083- SECURE Grid Act; American Privacy Rights Act; Energy storage generally; Minimum transfer capability; Federal Power Act; Artificial intelligence issues generally; Load growth, reliability, and resource adequacy generally; Data center issues generally; National Interest Electric Transmission Corridors; Nuclear issues generally; Draft legislation related to electric sector emissions reductions; Draft legislation related to offshore wind; Draft legislation related to public safety power shutoffs; Hydrogen policy generally; Electricity transmission and distribution infrastructure generally; Electric transmission policy; Clean energy issues generally; Clean energy technologies generally; Energy storage issues generally; Energy efficiency issues generally; FERC Orders 1920, 2022, 2023; 1977; FERC nominees; FERC issues generally; Offshore wind issues generally; Issues related to energy grid supply chain; Hydropower licensing and re-licensing; Hydrogen policy generally; Draft legislation related to cybersecurity; Draft legislation related to security and data; Distribution transformers.

Tax policy issues affecting local news organizations, including tax credits and payroll tax relief. H.R. 4756 - Community News and Small Business Support Act.

Tax policy issues affecting local news organizations, including tax credits and payroll tax relief. H.R. 4756 - Community News and Small Business Support Act.

Repeal Section 6001 of the Affordable Care Act - section 6001 prohibits expansion of physician-led hospitals - including related provisions in H.R. 977/S. 470, the Patient Access to Higher Quality Care Act; and in H.R. 9001, the Physician Led and Rural Access to Quality Care Act, to revise certain physician self-referral exemptions relating to physician-owned hospitals in rural areas; and related issues regarding hospital competition and consolidation. Center for Medicare & Medicaid Innovation demonstration to expand patient access to physician-led hospitals. Reform Medicare Advantage prior authorization, including related provisions in: H.R. 4968, the GOLD Card Act; H.R. 4822, the Health Care Price Transparency Act; H.R. 5378, the Lower Costs, More Transparency Act; and S. 4518/S. 4532/H.R. 8702, to establish requirements with respect to the use of prior authorization under Medicare Advantage plans. Advocacy related to H.R. 8246, Second Chances for Rural Hospitals Act, and access to physician-led entities.

Repeal Section 6001 of the Affordable Care Act - section 6001 prohibits expansion of physician-led hospitals - including related provisions in H.R. 977/S. 470, the Patient Access to Higher Quality Care Act; and in Draft Legislation by Rep. Burgess to amend title XVIII of the Social Security Act to revise certain physician self-referral exemptions relating to physician-owned hospitals in rural areas; and related issues regarding hospital competition and consolidation. Center for Medicare & Medicaid Innovation demonstration to expand patient access to physician-led hospitals. Reform Medicare Advantage prior authorization, including related provisions in: H.R. 4968, the GOLD Card Act; H.R. 4822, the Health Care Price Transparency Act; H.R. 5378, the Lower Costs, More Transparency Act; and S. 4518/S. 4532/H.R. 8702, to establish requirements with respect to the use of prior authorization under Medicare Advantage plans.

Adequacy of Medicare physician payments for physicians and implementation of the Medicare Access and CHIP Reauthorization Act, including related provisions in: (1) S. 4935 Physician Fee Stabilization Act and H.R. 6545, the Physician Fee Schedule Update and Improvements Act, including provisions to increase the work geographic index, increase the Medicare physician fee schedule conversion factor and extend and modify incentive payments for participation in eligible alternative payment models; (2) H.R. 6683, the Preserving Seniors Access to Physicians Act; and (3) H.R. 2474, the Strengthening Medicare for Patients and Providers Act. Issues related to adequate network coverage for ophthalmology care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, including related provisions in: H.R. 4822, the Health Care Price Transparency Act; H.R. 5378, the Lower Costs, More Transparency Act; and S. 4518/S. 4532/H.R. 8702, to establish requirements with respect to the use of prior authorization under Medicare Advantage plans. Medicare reimbursement for telemedicine, including related provisions in S. 3430, the Better Mental Health Care, Lower Costs Drugs, and Extenders Act, including Sec. 105 regarding Medicare payment for mental health services furnished through telehealth, and Sec. 107 regarding communications regarding telehealth and interstate licensure requirements; H.R. 7623, The Telehealth Modernization Act of 2024; SEC. 101. Extension of Certain Telehealth Flexibilities; H.R. 8261, the Preserving Telehealth, Hospital, and Ambulance Access Act; Section 2, extending Medicare Telehealth Flexibilities. Use of step therapy in Medicare and health insurance coverage, including related provisions in H.R. 2630/S. 652, the Safe Step Act. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including monitor CMMI Medicare Part B drug-related demonstrations.

Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP ReauthorizationAct (MACRA), including regulatory relief for physicians in the MACRA Quality Payment Program, evaluation and management (E/M) codes andrelated legislative issues related to payment for E/M codes, and qualified clinical data registries, including Medicare physician payment provisions in:(1) S. 3430, the Better Mental Health Care, Lower-Cost Drugs, and Extenders Act, Sec. 403 to extend work geographic index floor under Medicare; Sec. 404 to extend incentive payments for participation in eligible alternative payment models; and Sec. 407 to increase support for physicians and other professionals in adjusting to Medicare payment changes; (2) H.R. 6545, the Physician Fee Schedule Update and Improvements Act, including provisions to increase the work geographic index, increase the Medicare physician fee schedule conversion factor and extend and modify incentive payments for participation in eligible alternative payment models; and (3) H.R. 4366, the Consolidated Appropriations Act, 2024, P.L. 118-42: Sec.304, Extending Incentive Payments for Participation in Eligible Alternative Payment Models; and Sec. 305, Temporary Payment Increase under the Medicare Physician Fee Schedule to Account for Exceptional Circumstances and Atypical Timing of Enactment. Maintain patient access to In-Office Ancillary Services. Issues related to adequate network coverage for ophthalmology care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, including related provisions in: H.R. 4822, the Health Care Price Transparency Act; H.R. 5378, the Lower Costs, More Transparency Act; and S. 4518/S. 4532/H.R. 8702, to establish requirements with respect to the use of prior authorization under Medicare Advantage plans. MA plan provider directory accuracy issues, including related provisions in S. 3430, the Better Mental Health Care, Lower Cost Drugs, and Extenders Act of 2023, in Sec. 109, to require MA plans to maintain accurate provider directories on a public website. Legislative issues regarding implementation of Meaningful Use of Electronic Health Records. Medicare reimbursement for telemedicine, including related provisions in S. 3430, the Better Mental Health Care, Lower Costs Drugs, and Extenders Act, including Sec. 105 regarding Medicare payment for mental health services furnished through telehealth, and Sec. 107 regarding communications regarding telehealth and interstate licensure requirements; H.R. 7623, The Telehealth Modernization Act of 2024; SEC. 101. Extension of Certain Telehealth Flexibilities; H.R. 8261, the Preserving Telehealth, Hospital, and Ambulance Access Act; Section 2, extending Medicare Telehealth Flexibilities. Medicare RAC reform and use of step therapy in Medicare and health insurance coverage including related provisions in H.R. 2630/S. 652, the SafeStep Act. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including monitor CMMI Medicare Part B drug-related demonstrations.

Adequacy of Medicare physician payments for physicians and implementation of the Medicare Access and CHIP Reauthorization Act, including related provisions in: (1) S. 4935 Physician Fee Stabilization Act and H.R. 6545, the Physician Fee Schedule Update and Improvements Act, including provisions to increase the work geographic index, increase the Medicare physician fee schedule conversion factor and extend and modify incentive payments for participation in eligible alternative payment models; (2) H.R. 6683, the Preserving Seniors Access to Physicians Act; (3) H.R. 2474, the Strengthening Medicare for Patients and Providers Act; and (4) HR ____ Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025-related to physician payment adjustment of 2.5%. Issues related to adequate network coverage for ophthalmology care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, including related provisions in: H.R. 4822, the Health Care Price Transparency Act; H.R. 5378, the Lower Costs, More Transparency Act; and S. 4518/S. 4532/H.R. 8702, to establish requirements with respect to the use of prior authorization under Medicare Advantage plans. Medicare reimbursement for telemedicine, including related provisions in S. 3430, the Better Mental Health Care, Lower Costs Drugs, and Extenders Act, including Sec. 105 regarding Medicare payment for mental health services furnished through telehealth, and Sec. 107 regarding communications regarding telehealth and interstate licensure requirements; H.R. 7623, The Telehealth Modernization Act of 2024; SEC. 101. Extension of Certain Telehealth Flexibilities; H.R. 8261, the Preserving Telehealth, Hospital, and Ambulance Access Act; Section 2, extending Medicare Telehealth Flexibilities. Use of step therapy in Medicare and health insurance coverage, including related provisions in H.R. 2630/S. 652, the Safe Step Act. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including monitor CMMI Medicare Part B drug-related demonstrations.

Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act (MACRA), including regulatory relief for physicians in the MACRA Quality Payment Program, evaluation and management (E/M) codes and related legislative issues related to payment for E/M codes, and qualified clinical data registries, including Medicare physician payment provisions in: (1) S. 3430, the Better Mental Health Care, Lower-Cost Drugs, and Extenders Act, Sec. 403 to extend work geographic index floor under Medicare; Sec. 404 to extend incentive payments for participation in eligible alternative payment models; and Sec. 407 to increase support for physicians and other professionals in adjusting to Medicare payment changes; (2) H.R. 6545, the Physician Fee Schedule Update and Improvements Act, including provisions to increase the work geographic index, increase the Medicare physician fee schedule conversion factor and extend and modify incentive payments for participation in eligible alternative payment models; and (3) H.R. 4366, the Consolidated Appropriations Act, 2024, P.L. 118-42: Sec. 304, Extending Incentive Payments for Participation in Eligible Alternative Payment Models; and Sec. 305, Temporary Payment Increase under the Medicare Physician Fee Schedule to Account for Exceptional Circumstances and Atypical Timing of Enactment. Maintain patient access to In-Office Ancillary Services. Issues related to adequate network coverage for ophthalmology care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, including related provisions in: (1) H.R. 4822, the Health Care Price Transparency Act, to require Medicare Advantage plans to institute electronic prior authorization and establish requirements related to real time decisions; and (2) prior authorization transparency requirements included in H.R. 5378, the Lower Costs, More Transparency Act, and H.R. 4822, the Health Care Price Transparency Act; and MA plan provider directory accuracy issues, including provisions in S. 3430, the Better Mental Health Care, Lower Cost Drugs, and Extenders Act of 2023, in Sec. 109, to require MA plans to maintain accurate provider directories on a public website. Legislative issues regarding implementation of Meaningful Use of Electronic Health Records. Medicare reimbursement for telemedicine, including related provisions in S. 3430, the Better Mental Health Care, Lower Costs Drugs, and Extenders Act, including Sec. 105 regarding Medicare payment for mental health services furnished through telehealth, and Sec. 107 regarding communications regarding telehealth and interstate licensure requirements. Medicare RAC reform and use of step therapy in Medicare and health insurance coverage including related provisions in H.R. 2630/S. 652, the Safe Step Act. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including monitor CMMI Medicare Part B drug-related demonstrations.

Issues related to Medicare Part D and prescription drug pricing and patient access, including monitor implementation of related provisions in H.R. 5376, the Inflation Reduction Act of 2022 (P.L. 117-169), including provisions in Title 1, Subtitle B - Prescription Drug Pricing Reform: Part 1, Lowering Prices Through Drug Price Negotiation; Part 2, Prescription Drug Inflation Rebates; and Part 3, Part D Improvements and Maximum Out-of-Pocket Cap for Medicare Beneficiaries. Issues related to pharmacy benefit manager transparency, including related provisions in S. 2973, the Modernizing and Ensuring PBM Accountability Act, H.R. 5378, the Lower Costs, More Transparency Act, H.R. 4822, the Health Care Price Transparency Act; H.R. 2880, the Protecting Patients Against PBM Abuses Act, including provisions to establish new requirements for PBMs in Medicare Part D; and H.R. 5385, the Medicare PBM Accountability Act, including provisions to enhance PBM reporting requirements and reporting drug pricing information to HHS.

Repeal Section 6001 of the Affordable Care Act - section 6001 prohibits expansion of physician-led hospitals - including related provisions in H.R. 977/S. 470, the Patient Access to Higher Quality Care Act; and in H.R. 9001, the Physician Led and Rural Access to Quality Care Act, to revise certain physician self-referral exemptions relating to physician-owned hospitals in rural areas; and related issues regarding hospital competition and consolidation. Center for Medicare & Medicaid Innovation demonstration to expand patient access to physician-led hospitals. Reform Medicare Advantage prior authorization, including related provisions in: H.R. 4968, the GOLD Card Act; H.R. 4822, the Health Care Price Transparency Act; H.R. 5378, the Lower Costs, More Transparency Act; and S. 4518/S. 4532/H.R. 8702, to establish requirements with respect to the use of prior authorization under Medicare Advantage plans. Advocacy related to H.R. 8246, Second Chances for Rural Hospitals Act, and access to physician-led entities.

Repeal Section 6001 of the Affordable Care Act - section 6001 prohibits expansion of physician-led hospitals - including related provisions in H.R. 977/S. 470, the Patient Access to Higher Quality Care Act; and in Draft Legislation by Rep. Burgess to amend title XVIII of the Social Security Act to revise certain physician self-referral exemptions relating to physician-owned hospitals in rural areas; and related issues regarding hospital competition and consolidation. Center for Medicare & Medicaid Innovation demonstration to expand patient access to physician-led hospitals. Reform Medicare Advantage prior authorization, including related provisions in the GOLD Card Act, H.R. 4968; H.R. 4822, the Health Care Price Transparency Act - including requirements for Medicare Advantage electronic prior authorization and real-time decisions; and prior authorization transparency provisions in H.R. 4822, and H.R. 5378, the Lower Costs, More Transparency Act.

Repeal Section 6001 of the Affordable Care Act - section 6001 prohibits expansion of physician-led hospitals - including related provisions in H.R. 977/S. 470, the Patient Access to Higher Quality Care Act; and in H.R. 9001, the Physician Led and Rural Access to Quality Care Act, to revise certain physician self-referral exemptions relating to physician-owned hospitals in rural areas; and related issues regarding hospital competition and consolidation. Center for Medicare & Medicaid Innovation demonstration to expand patient access to physician-led hospitals. Reform Medicare Advantage prior authorization, including related provisions in: H.R. 4968, the GOLD Card Act; H.R. 4822, the Health Care Price Transparency Act; H.R. 5378, the Lower Costs, More Transparency Act; and S. 4518/S. 4532/H.R. 8702, to establish requirements with respect to the use of prior authorization under Medicare Advantage plans. Advocacy related to H.R. 8246, Second Chances for Rural Hospitals Act, and access to physician-led entities.

Repeal Section 6001 of the Affordable Care Act - section 6001 prohibits expansion of physician-led hospitals - including related provisions in H.R. 977/S. 470, the Patient Access to Higher Quality Care Act; and in H.R. 9001, the Physician Led and Rural Access to Quality Care Act, to revise certain physician self-referral exemptions relating to physician-owned hospitals in rural areas; and related issues regarding hospital competition and consolidation. Center for Medicare & Medicaid Innovation demonstration to expand patient access to physician-led hospitals. Reform Medicare Advantage prior authorization, including related provisions in: H.R. 4968, the GOLD Card Act; H.R. 4822, the Health Care Price Transparency Act; H.R. 5378, the Lower Costs, More Transparency Act; and S. 4518/S. 4532/H.R. 8702, to establish requirements with respect to the use of prior authorization under Medicare Advantage plans. Advocacy related to H.R. 8246, Second Chances for Rural Hospitals Act, and access to physician-led entities.

Repeal Section 6001 of the Affordable Care Act - section 6001 prohibits expansion of physician-led hospitals - including related provisions in H.R. 977/S. 470, the Patient Access to Higher Quality Care Act; and in Draft Legislation by Rep. Burgess to amend title XVIII of the Social Security Act to revise certain physician self-referral exemptions relating to physician-owned hospitals in rural areas; and related issues regarding hospital competition and consolidation. Center for Medicare & Medicaid Innovation demonstration to expand patient access to physician-led hospitals. Reform Medicare Advantage prior authorization, including related provisions in: H.R. 4968, the GOLD Card Act; H.R. 4822, the Health Care Price Transparency Act; H.R. 5378, the Lower Costs, More Transparency Act; and S. 4518/S. 4532/H.R. 8702, to establish requirements with respect to the use of prior authorization under Medicare Advantage plans.

Repeal Section 6001 of the Affordable Care Act - section 6001 prohibits expansion of physician-led hospitals - including related provisions in H.R. 977/S. 470, the Patient Access to Higher Quality Care Act; and in Draft Legislation by Rep. Burgess to amend title XVIII of the Social Security Act to revise certain physician self-referral exemptions relating to physician-owned hospitals in rural areas; and related issues regarding hospital competition and consolidation. Center for Medicare & Medicaid Innovation demonstration to expand patient access to physician-led hospitals. Reform Medicare Advantage prior authorization, including related provisions in the GOLD Card Act, H.R. 4968; H.R. 4822, the Health Care Price Transparency Act - including requirements for Medicare Advantage electronic prior authorization and real-time decisions; and prior authorization transparency provisions in H.R. 4822, and H.R. 5378, the Lower Costs, More Transparency Act.

Issues regarding stadium construction; RFK stadium revitalization H.R.4984 - D.C. Robert F. Kennedy Memorial Stadium Campus Revitalization Act.

Issues regarding stadium construction; RFK stadium revitalization H.R.4984 - D.C. Robert F. Kennedy Memorial Stadium Campus Revitalization Act.

Issues regarding stadium construction; RFK stadium revitalization H.R.4984 - D.C. Robert F. Kennedy Memorial Stadium Campus Revitalization Act.

Issues regarding stadium construction; RFK stadium revitalization H.R.4984 - D.C. Robert F. Kennedy Memorial Stadium Campus Revitalization Act.

S. 2651, the SITE Act; S. 1456, the SPUR Act; S. 1399, the Building American Energy Security Act; S. 1521, Community and Hydropower Improvement Act; S.914, Energy Threat Analysis Center Establishment Act; H.R. 4505, the Hydropower Clean Energy Future Act; H.R. 6747, the Clean Electricity and Transmission Acceleration Act; H.R. 6185, the GRID Act; PEER Act discussion draft; H.R. 6747, Clean Electricity and Transmission Acceleration Act; S. 2827, BIG WIRES; S. 4027, the SPEED and Reliability Act; H.R.1389, GRID Act H.R. 5075, Ethics in Energy Act; H.R. 7624/S. 3918, the Advancing GETs Act; H.R.7171/S. 3627, Distribution Transformer Efficiency and Supply Chain Reliability Act of 2024 H.R. 2864, Countering CCP Drones Act H.R. 8416 - Drones for First Responders Act; American Privacy Rights Act; Energy storage generally; Minimum transfer capability; Federal Power Act; Artificial intelligence issues generally; Load growth and resource adequacy generally; Data center issues generally; National Interest Electric Transmission Corridors; Nuclear issues generally; Draft legislation related to electric sector emissions reductions; Draft legislation related to offshore wind; Draft legislation related to public safety power shutoffs; Hydrogen policy generally; Electricity transmission and distribution infrastructure generally; Electric transmission policy; Clean energy issues generally; Clean energy technologies generally; Energy storage issues generally; Energy efficiency issues generally; FERC Orders 1920, 2022, 2023; 1977 FERC nominees; FERC issues generally; Offshore wind issues generally; Issues related to energy grid supply chain; Issues related to reliability and resource adequacy generally; Hydropower licensing and re-licensing; Hydrogen policy generally; Draft legislation related to cybersecurity; Draft legislation related to security and data; Distribution transformers.

S. 2651, the SITE Act; S. 1456, the SPUR Act; S. 1399, the Building American Energy Security Act; S. 1521, Community and Hydropower Improvement Act; S.914, Energy Threat Analysis Center Establishment Act; H.R. 4505, the Hydropower Clean Energy Future Act; H.R. 6747, the Clean Electricity and Transmission Acceleration Act; H.R. 4505, the Hydropower Clean Energy Future Act; H.R. 6185, the GRID Act PEER Act discussion draft; H.R. 6747, Clean Electricity and Transmission Acceleration Act; S. 2827, BIG WIRES; S. 4027, the SPEED and Reliability Act; H.R.1389, GRID Act H.R. 5075, Ethics in Energy Act; H.R. 7624/S. 3918, the Advancing GETs Act; H.R.7171/S. 3627, Distribution Transformer Efficiency and Supply Chain Reliability Act of 2024 H.R. 2864, Countering CCP Drones Act Minimum transfer capability; Federal Power Act; Artificial intelligence issues generally; Data center issues generally; Draft legislation related to transmission; Draft legislation related to electric vehicle charging infrastructure Draft legislation related to offshore wind; Draft legislation related to public safety power shutoffs; Hydrogen policy generally; Electricity transmission and distribution infrastructure generally; Electric transmission policy; Clean energy issues generally; Clean energy technologies generally; Energy storage issues generally; Energy efficiency issues generally; FERC issues generally; Offshore wind issues generally; Issues related to energy grid supply chain; Issues related to reliability and resource adequacy generally; Hydropower licensing and re-licensing; Hydrogen policy generally; Draft legislation related to cybersecurity; Draft legislation related to security and data; Distribution transformers.

S.4753 - Energy Permitting Reform Act of 2024; S. 2651, the SITE Act; S. 1456, the SPUR Act; S. 1399, the Building American Energy Security Act; S. 1521, Community and Hydropower Improvement Act; S.914, Energy Threat Analysis Center Establishment Act; H.R. 4505, the Hydropower Clean Energy Future Act; H.R. 6747, the Clean Electricity and Transmission Acceleration Act; H.R. 6185, the GRID Act; PEER Act discussion draft; H.R. 6747, Clean Electricity and Transmission Acceleration Act; S. 2827, BIG WIRES; S. 4027, the SPEED and Reliability Act; H.R.1389, GRID Act; S. 4719- Guaranteeing Resilient Installations for Defense (GRID) Act of 2024; H.R. 5075, Ethics in Energy Act; H.R. 7624/S. 3918, the Advancing GETs Act; H.R.7171/S. 3627, Distribution Transformer Efficiency and Supply Chain Reliability Act of 2024; H.R. 2864, Countering CCP Drones Act; H.R. 8416 - Drones for First Responders Act; H.R. 9083- SECURE Grid Act; American Privacy Rights Act; Energy storage generally; Minimum transfer capability; Federal Power Act; Artificial intelligence issues generally; Load growth, reliability, and resource adequacy generally; Data center issues generally; National Interest Electric Transmission Corridors; Nuclear issues generally; Draft legislation related to electric sector emissions reductions; Draft legislation related to offshore wind; Draft legislation related to public safety power shutoffs; Hydrogen policy generally; Electricity transmission and distribution infrastructure generally; Electric transmission policy; Clean energy issues generally; Clean energy technologies generally; Energy storage issues generally; Energy efficiency issues generally; FERC Orders 1920, 2022, 2023; 1977; FERC nominees; FERC issues generally; Offshore wind issues generally; Issues related to energy grid supply chain; Hydropower licensing and re-licensing; Hydrogen policy generally; Draft legislation related to cybersecurity; Draft legislation related to security and data; Distribution transformers.

S.4753 - Energy Permitting Reform Act of 2024; S. 2651, the SITE Act; S. 1456, the SPUR Act; S. 1399, the Building American Energy Security Act; S. 1521, Community and Hydropower Improvement Act; S.914, Energy Threat Analysis Center Establishment Act; H.R. 4505, the Hydropower Clean Energy Future Act; H.R. 6747, the Clean Electricity and Transmission Acceleration Act; H.R. 6185, the GRID Act; PEER Act discussion draft; H.R. 6747, Clean Electricity and Transmission Acceleration Act; S. 2827, BIG WIRES; S. 4027, the SPEED and Reliability Act; H.R.1389, GRID Act; S. 4719/H.R. 1389- Guaranteeing Resilient Installations for Defense (GRID) Act of 2024; H.R. 5075, Ethics in Energy Act; H.R. 7624/S. 3918, the Advancing GETs Act; H.R.7171/S. 3627, Distribution Transformer Efficiency and Supply Chain Reliability Act of 2024 H.R. 2864, Countering CCP Drones Act H.R. 8416 - Drones for First Responders Act; H.R. 9083- SECURE Grid Act; American Privacy Rights Act; S. 4664- Department of Energy AI Act; Energy storage generally; Minimum transfer capability; Federal Power Act; Artificial intelligence issues generally; Load growth, reliability, and resource adequacy generally; Data center issues generally; National Interest Electric Transmission Corridors; Nuclear issues generally; Draft legislation related to electric sector emissions reductions; Draft legislation related to offshore wind; Draft legislation related to public safety power shutoffs; Hydrogen policy generally; Electricity transmission and distribution infrastructure generally; Electric transmission policy; Clean energy issues generally; Clean energy technologies generally; Energy storage issues generally; Energy efficiency issues generally; FERC Orders 1920, 2022, 2023; 1977; FERC nominees; FERC issues generally; Offshore wind issues generally; Issues related to energy grid supply chain; Hydropower licensing and re-licensing; Hydrogen policy generally; Draft legislation related to cybersecurity; Draft legislation related to security and data; Distribution transformers.

Repeal Section 6001 of the Affordable Care Act - section 6001 prohibits expansion of physician-led hospitals - including related provisions in H.R. 977/S. 470, the Patient Access to Higher Quality Care Act; and in Draft Legislation by Rep. Burgess to amend title XVIII of the Social Security Act to revise certain physician self-referral exemptions relating to physician-owned hospitals in rural areas; and related issues regarding hospital competition and consolidation. Center for Medicare & Medicaid Innovation demonstration to expand patient access to physician-led hospitals. Reform Medicare Advantage prior authorization, including related provisions in: H.R. 4968, the GOLD Card Act; H.R. 4822, the Health Care Price Transparency Act; H.R. 5378, the Lower Costs, More Transparency Act; and S. 4518/S. 4532/H.R. 8702, to establish requirements with respect to the use of prior authorization under Medicare Advantage plans.

Adequacy of Medicare physician payments for physicians and implementation of the Medicare Access and CHIP Reauthorization Act, including related provisions in: (1) S. 4935 Physician Fee Stabilization Act and H.R. 6545, the Physician Fee Schedule Update and Improvements Act, including provisions to increase the work geographic index, increase the Medicare physician fee schedule conversion factor and extend and modify incentive payments for participation in eligible alternative payment models; (2) H.R. 6683, the Preserving Seniors Access to Physicians Act; (3) H.R. 2474, the Strengthening Medicare for Patients and Providers Act; and (4) HR ____ Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025-related to physician payment adjustment of 2.5%. Issues related to adequate network coverage for ophthalmology care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, including related provisions in: H.R. 4822, the Health Care Price Transparency Act; H.R. 5378, the Lower Costs, More Transparency Act; and S. 4518/S. 4532/H.R. 8702, to establish requirements with respect to the use of prior authorization under Medicare Advantage plans. Medicare reimbursement for telemedicine, including related provisions in S. 3430, the Better Mental Health Care, Lower Costs Drugs, and Extenders Act, including Sec. 105 regarding Medicare payment for mental health services furnished through telehealth, and Sec. 107 regarding communications regarding telehealth and interstate licensure requirements; H.R. 7623, The Telehealth Modernization Act of 2024; SEC. 101. Extension of Certain Telehealth Flexibilities; H.R. 8261, the Preserving Telehealth, Hospital, and Ambulance Access Act; Section 2, extending Medicare Telehealth Flexibilities. Use of step therapy in Medicare and health insurance coverage, including related provisions in H.R. 2630/S. 652, the Safe Step Act. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including monitor CMMI Medicare Part B drug-related demonstrations.

Adequacy of Medicare physician payments for physicians and implementation of the Medicare Access and CHIP Reauthorization Act, including related provisions in: (1) S. 4935 Physician Fee Stabilization Act and H.R. 6545, the Physician Fee Schedule Update and Improvements Act, including provisions to increase the work geographic index, increase the Medicare physician fee schedule conversion factor and extend and modify incentive payments for participation in eligible alternative payment models; (2) H.R. 6683, the Preserving Seniors Access to Physicians Act; and (3) H.R. 2474, the Strengthening Medicare for Patients and Providers Act. Issues related to adequate network coverage for ophthalmology care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, including related provisions in: H.R. 4822, the Health Care Price Transparency Act; H.R. 5378, the Lower Costs, More Transparency Act; and S. 4518/S. 4532/H.R. 8702, to establish requirements with respect to the use of prior authorization under Medicare Advantage plans. Medicare reimbursement for telemedicine, including related provisions in S. 3430, the Better Mental Health Care, Lower Costs Drugs, and Extenders Act, including Sec. 105 regarding Medicare payment for mental health services furnished through telehealth, and Sec. 107 regarding communications regarding telehealth and interstate licensure requirements; H.R. 7623, The Telehealth Modernization Act of 2024; SEC. 101. Extension of Certain Telehealth Flexibilities; H.R. 8261, the Preserving Telehealth, Hospital, and Ambulance Access Act; Section 2, extending Medicare Telehealth Flexibilities. Use of step therapy in Medicare and health insurance coverage, including related provisions in H.R. 2630/S. 652, the Safe Step Act. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including monitor CMMI Medicare Part B drug-related demonstrations.

Legislative and regulatory issues related to independent pharmacists. PBM Issues, including S.2973 - Modernizing and Ensuring PBM Accountability Act. H.R.5378 - Lower Costs, More Transparency Act.

Issues related to Medicare Part D and prescription drug pricing and patient access, including monitor implementation of related provisions in H.R. 5376, the Inflation Reduction Act of 2022 (P.L. 117-169), including provisions in Title 1, Subtitle B - Prescription Drug Pricing Reform: Part 1, Lowering Prices Through Drug Price Negotiation; Part 2, Prescription Drug Inflation Rebates; and Part 3, Part D Improvements and Maximum Out-of-Pocket Cap for Medicare Beneficiaries. Issues related to pharmacy benefit manager transparency, including related provisions in S. 2973, the Modernizing and Ensuring PBM Accountability Act, H.R. 5378, the Lower Costs, More Transparency Act, H.R. 4822, the Health Care Price Transparency Act; H.R. 2880, the Protecting Patients Against PBM Abuses Act, including provisions to establish new requirements for PBMs in Medicare Part D; and H.R. 5385, the Medicare PBM Accountability Act, including provisions to enhance PBM reporting requirements and reporting drug pricing information to HHS.

Issues regarding Pill Penalty caused by the Inflation Reduction Act (IRA) P.L. No: 117-169, drug pricing and efforts to create a Neuroscience Center of Excellence at FDA. PBM Issues, including S.2973 - Modernizing and Ensuring PBM Accountability Act and H.R.5378 - Lower Costs, More Transparency Act.

Legislative and regulatory issues related to independent pharmacists. PBM Issues, including S.2973 - Modernizing and Ensuring PBM Accountability Act. H.R.5378 - Lower Costs, More Transparency Act.

Repeal Section 6001 of the Affordable Care Act - section 6001 prohibits expansion of physician-led hospitals - including related provisions in H.R. 977/S. 470, the Patient Access to Higher Quality Care Act; and in H.R. 9001, the Physician Led and Rural Access to Quality Care Act, to revise certain physician self-referral exemptions relating to physician-owned hospitals in rural areas; and related issues regarding hospital competition and consolidation. Center for Medicare & Medicaid Innovation demonstration to expand patient access to physician-led hospitals. Reform Medicare Advantage prior authorization, including related provisions in: H.R. 4968, the GOLD Card Act; H.R. 4822, the Health Care Price Transparency Act; H.R. 5378, the Lower Costs, More Transparency Act; and S. 4518/S. 4532/H.R. 8702, to establish requirements with respect to the use of prior authorization under Medicare Advantage plans. Advocacy related to H.R. 8246, Second Chances for Rural Hospitals Act, and access to physician-led entities.

Issues regarding Pill Penalty caused by the Inflation Reduction Act (IRA) P.L. No: 117-169, drug pricing and efforts to create a Neuroscience Center of Excellence at FDA. PBM Issues, including S.2973 - Modernizing and Ensuring PBM Accountability Act and H.R.5378 - Lower Costs, More Transparency Act. Issues regarding effective solutions for improving clinical care in long-term care settings and other solutions aimed at improving the diagnosis and management of neuropsychiatric symptoms (NPS) in dementia.

Issues regarding Pill Penalty caused by the Inflation Reduction Act (IRA) P.L. No: 117-169, drug pricing and efforts to create a Neuroscience Center of Excellence at FDA. PBM Issues, including S.2973 - Modernizing and Ensuring PBM Accountability Act and H.R.5378 - Lower Costs, More Transparency Act.

Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act (MACRA), including regulatory relief for physicians in the MACRA Quality Payment Program, evaluation and management (E/M) codes and related legislative issues related to payment for E/M codes, and qualified clinical data registries, including Medicare physician payment provisions in: (1) S. 3430, the Better Mental Health Care, Lower-Cost Drugs, and Extenders Act, Sec. 403 to extend work geographic index floor under Medicare; Sec. 404 to extend incentive payments for participation in eligible alternative payment models; and Sec. 407 to increase support for physicians and other professionals in adjusting to Medicare payment changes; (2) H.R. 6545, the Physician Fee Schedule Update and Improvements Act, including provisions to increase the work geographic index, increase the Medicare physician fee schedule conversion factor and extend and modify incentive payments for participation in eligible alternative payment models; and (3) H.R. 4366, the Consolidated Appropriations Act, 2024, P.L. 118-42: Sec. 304, Extending Incentive Payments for Participation in Eligible Alternative Payment Models; and Sec. 305, Temporary Payment Increase under the Medicare Physician Fee Schedule to Account for Exceptional Circumstances and Atypical Timing of Enactment. Maintain patient access to In-Office Ancillary Services. Issues related to adequate network coverage for ophthalmology care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, including related provisions in: (1) H.R. 4822, the Health Care Price Transparency Act, to require Medicare Advantage plans to institute electronic prior authorization and establish requirements related to real time decisions; and (2) prior authorization transparency requirements included in H.R. 5378, the Lower Costs, More Transparency Act, and H.R. 4822, the Health Care Price Transparency Act; and MA plan provider directory accuracy issues, including provisions in S. 3430, the Better Mental Health Care, Lower Cost Drugs, and Extenders Act of 2023, in Sec. 109, to require MA plans to maintain accurate provider directories on a public website. Legislative issues regarding implementation of Meaningful Use of Electronic Health Records. Medicare reimbursement for telemedicine, including related provisions in S. 3430, the Better Mental Health Care, Lower Costs Drugs, and Extenders Act, including Sec. 105 regarding Medicare payment for mental health services furnished through telehealth, and Sec. 107 regarding communications regarding telehealth and interstate licensure requirements. Medicare RAC reform and use of step therapy in Medicare and health insurance coverage including related provisions in H.R. 2630/S. 652, the Safe Step Act. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including monitor CMMI Medicare Part B drug-related demonstrations.

Issues regarding Pill Penalty caused by the Inflation Reduction Act (IRA) P.L. No: 117-169, drug pricing and efforts to create a Neuroscience Center of Excellence at FDA. PBM Issues, including S.2973 - Modernizing and Ensuring PBM Accountability Act and H.R.5378 - Lower Costs, More Transparency Act. Issues regarding effective solutions for improving clinical care in long-term care settings and other solutions aimed at improving the diagnosis and management of neuropsychiatric symptoms (NPS) in dementia.

Repeal Section 6001 of the Affordable Care Act - section 6001 prohibits expansion of physician-led hospitals - including related provisions in H.R. 977/S. 470, the Patient Access to Higher Quality Care Act; and in H.R. 9001, the Physician Led and Rural Access to Quality Care Act, to revise certain physician self-referral exemptions relating to physician-owned hospitals in rural areas; and related issues regarding hospital competition and consolidation. Center for Medicare & Medicaid Innovation demonstration to expand patient access to physician-led hospitals. Reform Medicare Advantage prior authorization, including related provisions in: H.R. 4968, the GOLD Card Act; H.R. 4822, the Health Care Price Transparency Act; H.R. 5378, the Lower Costs, More Transparency Act; and S. 4518/S. 4532/H.R. 8702, to establish requirements with respect to the use of prior authorization under Medicare Advantage plans. Advocacy related to H.R. 8246, Second Chances for Rural Hospitals Act, and access to physician-led entities.

Repeal Section 6001 of the Affordable Care Act - section 6001 prohibits expansion of physician-led hospitals - including related provisions in H.R. 977/S. 470, the Patient Access to Higher Quality Care Act; and in Draft Legislation by Rep. Burgess to amend title XVIII of the Social Security Act to revise certain physician self-referral exemptions relating to physician-owned hospitals in rural areas; and related issues regarding hospital competition and consolidation. Center for Medicare & Medicaid Innovation demonstration to expand patient access to physician-led hospitals. Reform Medicare Advantage prior authorization, including related provisions in the GOLD Card Act, H.R. 4968; H.R. 4822, the Health Care Price Transparency Act - including requirements for Medicare Advantage electronic prior authorization and real-time decisions; and prior authorization transparency provisions in H.R. 4822, and H.R. 5378, the Lower Costs, More Transparency Act.

Legislative and regulatory issues related to independent pharmacists. PBM Issues, including S.2973 - Modernizing and Ensuring PBM Accountability Act. H.R.5378 - Lower Costs, More Transparency Act.

Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP ReauthorizationAct (MACRA), including regulatory relief for physicians in the MACRA Quality Payment Program, evaluation and management (E/M) codes andrelated legislative issues related to payment for E/M codes, and qualified clinical data registries, including Medicare physician payment provisions in:(1) S. 3430, the Better Mental Health Care, Lower-Cost Drugs, and Extenders Act, Sec. 403 to extend work geographic index floor under Medicare; Sec. 404 to extend incentive payments for participation in eligible alternative payment models; and Sec. 407 to increase support for physicians and other professionals in adjusting to Medicare payment changes; (2) H.R. 6545, the Physician Fee Schedule Update and Improvements Act, including provisions to increase the work geographic index, increase the Medicare physician fee schedule conversion factor and extend and modify incentive payments for participation in eligible alternative payment models; and (3) H.R. 4366, the Consolidated Appropriations Act, 2024, P.L. 118-42: Sec.304, Extending Incentive Payments for Participation in Eligible Alternative Payment Models; and Sec. 305, Temporary Payment Increase under the Medicare Physician Fee Schedule to Account for Exceptional Circumstances and Atypical Timing of Enactment. Maintain patient access to In-Office Ancillary Services. Issues related to adequate network coverage for ophthalmology care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, including related provisions in: H.R. 4822, the Health Care Price Transparency Act; H.R. 5378, the Lower Costs, More Transparency Act; and S. 4518/S. 4532/H.R. 8702, to establish requirements with respect to the use of prior authorization under Medicare Advantage plans. MA plan provider directory accuracy issues, including related provisions in S. 3430, the Better Mental Health Care, Lower Cost Drugs, and Extenders Act of 2023, in Sec. 109, to require MA plans to maintain accurate provider directories on a public website. Legislative issues regarding implementation of Meaningful Use of Electronic Health Records. Medicare reimbursement for telemedicine, including related provisions in S. 3430, the Better Mental Health Care, Lower Costs Drugs, and Extenders Act, including Sec. 105 regarding Medicare payment for mental health services furnished through telehealth, and Sec. 107 regarding communications regarding telehealth and interstate licensure requirements; H.R. 7623, The Telehealth Modernization Act of 2024; SEC. 101. Extension of Certain Telehealth Flexibilities; H.R. 8261, the Preserving Telehealth, Hospital, and Ambulance Access Act; Section 2, extending Medicare Telehealth Flexibilities. Medicare RAC reform and use of step therapy in Medicare and health insurance coverage including related provisions in H.R. 2630/S. 652, the SafeStep Act. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including monitor CMMI Medicare Part B drug-related demonstrations.

Issues related to Medicare Part D and prescription drug pricing and patient access, including monitor implementation of related provisions in H.R. 5376, the Inflation Reduction Act of 2022 (P.L. 117-169), including provisions in Title 1, Subtitle B - Prescription Drug Pricing Reform: Part 1, Lowering Prices Through Drug Price Negotiation; Part 2, Prescription Drug Inflation Rebates; and Part 3, Part D Improvements and Maximum Out-of-Pocket Cap for Medicare Beneficiaries. Issues related to pharmacy benefit manager transparency, including related provisions in S. 2973, the Modernizing and Ensuring PBM Accountability Act, H.R. 5378, the Lower Costs, More Transparency Act, H.R. 4822, the Health Care Price Transparency Act; H.R. 2880, the Protecting Patients Against PBM Abuses Act, including provisions to establish new requirements for PBMs in Medicare Part D; and H.R. 5385, the Medicare PBM Accountability Act, including provisions to enhance PBM reporting requirements and reporting drug pricing information to HHS.

S.4753 - Energy Permitting Reform Act of 2024; S. 2651, the SITE Act; S. 1456, the SPUR Act; S. 1399, the Building American Energy Security Act; S. 1521, Community and Hydropower Improvement Act; S.914, Energy Threat Analysis Center Establishment Act; H.R. 4505, the Hydropower Clean Energy Future Act; H.R. 6747, the Clean Electricity and Transmission Acceleration Act; H.R. 6185, the GRID Act; PEER Act discussion draft; H.R. 6747, Clean Electricity and Transmission Acceleration Act; S. 2827, BIG WIRES; S. 4027, the SPEED and Reliability Act; H.R.1389, GRID Act; S. 4719- Guaranteeing Resilient Installations for Defense (GRID) Act of 2024; H.R. 5075, Ethics in Energy Act; H.R. 7624/S. 3918, the Advancing GETs Act; H.R.7171/S. 3627, Distribution Transformer Efficiency and Supply Chain Reliability Act of 2024; H.R. 2864, Countering CCP Drones Act; H.R. 8416 - Drones for First Responders Act; H.R. 9083- SECURE Grid Act; American Privacy Rights Act; Energy storage generally; Minimum transfer capability; Federal Power Act; Artificial intelligence issues generally; Load growth, reliability, and resource adequacy generally; Data center issues generally; National Interest Electric Transmission Corridors; Nuclear issues generally; Draft legislation related to electric sector emissions reductions; Draft legislation related to offshore wind; Draft legislation related to public safety power shutoffs; Hydrogen policy generally; Electricity transmission and distribution infrastructure generally; Electric transmission policy; Clean energy issues generally; Clean energy technologies generally; Energy storage issues generally; Energy efficiency issues generally; FERC Orders 1920, 2022, 2023; 1977; FERC nominees; FERC issues generally; Offshore wind issues generally; Issues related to energy grid supply chain; Hydropower licensing and re-licensing; Hydrogen policy generally; Draft legislation related to cybersecurity; Draft legislation related to security and data; Distribution transformers.

S. 2651, the SITE Act; S. 1456, the SPUR Act; S. 1399, the Building American Energy Security Act; S. 1521, Community and Hydropower Improvement Act; S.914, Energy Threat Analysis Center Establishment Act; H.R. 4505, the Hydropower Clean Energy Future Act; H.R. 6747, the Clean Electricity and Transmission Acceleration Act; H.R. 4505, the Hydropower Clean Energy Future Act; H.R. 6185, the GRID Act PEER Act discussion draft; H.R. 6747, Clean Electricity and Transmission Acceleration Act; S. 2827, BIG WIRES; S. 4027, the SPEED and Reliability Act; H.R.1389, GRID Act H.R. 5075, Ethics in Energy Act; H.R. 7624/S. 3918, the Advancing GETs Act; H.R.7171/S. 3627, Distribution Transformer Efficiency and Supply Chain Reliability Act of 2024 H.R. 2864, Countering CCP Drones Act Minimum transfer capability; Federal Power Act; Artificial intelligence issues generally; Data center issues generally; Draft legislation related to transmission; Draft legislation related to electric vehicle charging infrastructure Draft legislation related to offshore wind; Draft legislation related to public safety power shutoffs; Hydrogen policy generally; Electricity transmission and distribution infrastructure generally; Electric transmission policy; Clean energy issues generally; Clean energy technologies generally; Energy storage issues generally; Energy efficiency issues generally; FERC issues generally; Offshore wind issues generally; Issues related to energy grid supply chain; Issues related to reliability and resource adequacy generally; Hydropower licensing and re-licensing; Hydrogen policy generally; Draft legislation related to cybersecurity; Draft legislation related to security and data; Distribution transformers.